Interactions between neural membrane glycerophospholipid and sphingolipid mediators: A recipe for neural cell survival or suicide
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The neural membranes contain phospholipids, sphingolipids, cholesterol, and proteins. Glycerophospholipids and sphingolipids are precursors for lipid mediators involved in signal transduction processes. Degradation of glycerophospholipids by phospholipase A 2(PLA 2) generates arachidonic acid (AA) and docosahexaenoic acids (DHA). Arachidonic acid is metabolized to eicosanoids and DHA is metabolized to docosanoids. The catabolism of glycosphingolipids generates ceramide, ceramide 1‐phosphate, sphingosine, and sphingosine 1‐phosphate. These metabolites modulate PLA 2 activity. Arachidonic acid, a product derived from glycerophospholipid catabolism by PLA 2, modulates sphingomyelinase (SMase), the enzyme that generates ceramide and phosphocholine. Furthermore, sphingosine 1‐phosphate modulates cyclooxygenase, an enzyme responsible for eicosanoid production in brain. This suggests that an interplay and cross talk occurs between lipid mediators of glycerophospholipid and glycosphingolipid metabolism in brain tissue. This interplay between metabolites of glycerophospholipid and sphingolipid metabolism may play an important role in initiation and maintenance of oxidative stress associated with neurologic disorders as well as in neural cell proliferation, differentiation, and apoptosis. Recent studies indicate that PLA 2 and SMase inhibitors can be used as neuroprotective and anti‐apoptotic agents. Development of novel inhibitors of PLA 2 and SMase may be useful for the treatment of oxidative stress, and apoptosis associated with neurologic disorders such as stroke, Alzheimer disease, Parkinson disease, and head and spinal cord injuries. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300218200 · Cited by 1,000 · cited 2×
“The action of a lipoxygenase-like enzyme on DHA produces 10,17S-docosatrienes and 17S-resolvins (Hong et al., 2003; Marcheselli et al., 2003; Serhan et al., 2004).”
BackgroundDocosahexaenoic acid: Membrane properties of a unique fatty acid
Stillwell, W., & Wassall, S. R. (2003) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(03)00101-4 · Cited by 872 · cited 1×
“PLA1, PLA2, PLC, and PLD have been purified and characterized from brain tissue (Hirashima et al., 1992; Pete et al., 1994; Fukami, 2002; Banno, 2002; Stillwell and Wassall, 2003; McDermott et al., 2004).”
BackgroundMarcheselli, V. L., Hong, S., Lukiw, W. J., Tian, X. H., Gronert, K., Musto, A., Hardy, M., Gimenez, J. M., Chiang, N., Serhan, C. N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305841200 · Cited by 802 · cited 2×
“The action of a lipoxygenase-like enzyme on DHA produces 10,17S-docosatrienes and 17S-resolvins (Hong et al., 2003; Marcheselli et al., 2003; Serhan et al., 2004).”
BackgroundMukherjee, P. K., Marcheselli, V. L., Serhan, C. N., & Bazan, N. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402531101 · Cited by 753 · cited 1×
“These receptors include resolvin D receptors (resoDR1), resolvin E receptors (resoER1), and neuroprotectin D receptors (NPDR) (Hong et al., 2003; Marcheselli et al., 2003; Serhan et al., 2004; Mukherjee et al., 2004).”
Neurotrophin Signaling Through the P75 Neurotrophin Receptor
Roux, P. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00016-3 · Cited by 717
Han, X., M. Holtzman, D., W. McKeel, D., Kelley, J., & Morris, J. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00997.x · Cited by 626 · cited 1×
“Increased levels of ceramide have been found in the CNS of patients or models of acute or chronic neurodegenerative disorders including Alzheimer disease, ischemia, and epilepsy (Herr et al., 1999; Han et al., 2002; Mikati et al., 2003; Lee et al., 2004; Ohtani et al., 2004).”
BackgroundFarooqui, A. A., Horrocks, L. A., & Farooqui, T. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00128-6 · Cited by 555
Self-citationLee, J.-T., Xu, J., Lee, J.-M., Ku, G., Han, X., Yang, D.-I., Chen, S., & Hsu, C. Y. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200307017 · Cited by 280
Effects of membrane lipids on ion channel structure and function
Tillman, T. S., & Cascio, M. (2003) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:38:2:161 · Cited by 265 · cited 2×
“The interaction of agonist with receptors results in enhancements of glycerophospholipid metabolism, which not only regulates the activities of membrane-bound enzymes and ion channels, but also modulates many physicochemical properties of neural membranes such as fluidity, lateral pressure profile, bilayer thickness,…”
BackgroundYagasaki, Y., Numakawa, T., Kumamaru, E., Hayashi, T., Su, T.-P., & Kunugi, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508157200 · Cited by 122 · cited 2×
“Scyphostatin, a sphingomyelinase inhibitor, retards the NGF-dependent Ca2+ increase and glutamate release, suggesting that a ceramide produced by sphingomyelinase may modulate the increase in Ca2+ and elevation in glutamate release (Numakawa et al., 2003; Yagasaki et al., 2006).”
Background
Cited by
Deregulation of sphingolipid metabolism in Alzheimer’s disease
He, X., Huang, Y., Li, B., Gong, C.-X., & Schuchman, E. H. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.010 · Cited by 516
Krämer, J., Kang, R., Grimm, L. M., De Cola, L., Picchetti, P., & Biedermann, F. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00746 · Cited by 449
Healy-Stoffel, M., & Levant, B. (2018) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527317666180412153612 · Cited by 133
“DHA is highly enriched in neuronal and synaptic membranes, suggesting an important role in neural cell signaling [46].”
BackgroundLipid metabolism in Alzheimer’s disease
Liu, Q., & Zhang, J. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1410-3 · Cited by 101
“Arachidonic acid plays a role in regulating the activity of many enzymes such as protein kinase A, protein kinase C, NAPDH oxidase, choline acetyltransferase, and caspase3([137]).”
BackgroundThe vascular contribution to Alzheimer's disease
Altman, R., & Rutledge, J. C. (2010) · Clinical Science · doi:10.1042/cs20100094 · Cited by 93
Metadata
- Authors
- Farooqui, A. A., Horrocks, L. A., & Farooqui, T.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2007-03-28
- Volume
- 85
- Issue
- 9
- Pages
- 1834-1850
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2015025117
- Cited by
- 119
- References
- 10
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interactions between neural membrane glycerophospholipid and sphingolipid mediators: A recipe for neural cell survival or suicide. https://app.cochat.ai/papers/10.1002/jnr.21268
- The paper
- Farooqui, A. A., Horrocks, L. A., & Farooqui, T. (2007). Interactions between neural membrane glycerophospholipid and sphingolipid mediators: A recipe for neural cell survival or suicide. Journal of Neuroscience Research. https://doi.org/10.1002/jnr.21268
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.